future glp-1 drugs drugs, even when they fail, are giving researchers new insight about obesity : NPR 3 Ways GLP-1 Drugs Could

Common cost-control strategies include: Fixed allowance caps: Employers set an annual or quarterly budget per employee, ensuring total program costs remain predictable

This creates both the urgency and economic justification for massive investment in treatment solutions

Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further

Regular follow-up is essential to assess therapeutic response, monitor glycemic and cardiovascular outcomes, and manage adverse effects

However, it's essential to consult your healthcare provider before starting any new supplement or dietary change to ensure it is safe and will not interact with your current medications